CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS

Etanercept (ETC), a soluble tumor necrosis factor-α (TNF-α) receptor, was registered for the treatment of spondyloarthritis in the Russian Federation in 2009. By now, results of prolonged treatment with this drug have been obtained in patients with ankylosing spondylitis (AS).Objective: to evaluate...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, T. V. Dubinina, Sh. F. Erdes
Format: Artigo
Sprog:Russo
Udgivet: IMA-PRESS LLC 2018-05-01
Serier:Научно-практическая ревматология
Fag:
etanercept
ankylosing spondylitis
axial spondyloarthritis
remission
Online adgang:https://rsp.mediar-press.net/rsp/article/view/2524
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker